# 2025-08147: FDA Puts Breast Milk Nutrient Testers into Official Safety Category

2025-08147, Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Breast Milk Macronutrients Test System, is a Federal Register rule from Health and Human Services Department, Food and Drug Administration published 2025-05-09, effective 2025-05-09; PRIA reads it as touching household money (as of 2026-10-16).

- Canonical: https://policyrisk.com/federal-register/2025-08147
- As of: 2026-10-16
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-08147
- Title: Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Breast Milk Macronutrients Test System
- Type: Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 19627
- Published: 2025-05-09
- Effective: 2025-05-09
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-16

## In one line

FDA Puts Breast Milk Nutrient Testers into Official Safety Category

## Summary

The FDA is officially putting the breast milk macronutrients test system into Class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps companies bring these helpful devices to moms and babies faster and safer. The new rules took effect on May 9, 2025, making it easier and quicker to get these tests to market without extra costs.

## Abstract

The Food and Drug Administration (FDA, Agency, or we) is classifying the breast milk macronutrients test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the breast milk macronutrients test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

## Effects PRIA read

- Breast milk macronutrient tests cleared faster: benefit, medium. The FDA officially classified the breast milk macronutrients test system as Class II (special controls) effective May 9, 2025; the classification was applicable on December 21, 2018. The device is defined to measure fat, protein, and total carbohydrate in human breast milk and the FDA says the chan…
- Manufacturers must meet specific test and label rules: cost, medium. Companies that market a breast milk macronutrients test system must follow Class II special controls and submit a premarket notification under section 510(k). Required special controls include a traceability plan, precision studies using at least three breast milk specimens at low/medium/high conce…
- Enables future devices to use 510(k) pathway: benefit, medium. Because FDA classified this device into Class II via the De Novo process, the breast milk macronutrients test system can serve as a predicate for future similar devices, allowing other device sponsors to use the less-burdensome 510(k) process rather than a De Novo request or premarket approval.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-08147 on federalregister.gov](https://www.federalregister.gov/documents/2025/05/09/2025-08147/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-breast-milk)
- [2025-08147 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-05-09/pdf/2025-08147.pdf)

## Related
- [Previous: 2025-08146, Medical Devices; Immunology and Microbiology Devices; Classification of the Cyt…](https://policyrisk.com/federal-register/2025-08146)
- [Next: 2025-08148, Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classifica…](https://policyrisk.com/federal-register/2025-08148)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-08147 (as of 2026-10-16).
